PharmAthene, Inc. (AMEX: PIP) has appointed Jeffrey W. Runge, M.D., to its Board of Directors. This appointment increases the number of members on the Board to 8. Dr. Runge is a Principal at The Chertoff group. He is also the Founder and President of Biologue, Inc.
Xplosive Stocks, an online financial publication, provides investors timely stock market information.
Sign Up Today for our Free Stock Newsletter
He served in the Bush administration from 2001-August of 2008, first as the head of the National Highway Traffic Safety Administration. In September 2005, he then became the Department of Homeland Security's first Chief Medical Officer and had founded the DHS Office of Health Affairs in 2007. He graduated from the Medical University of South Carolina with his medical degree. He also graduated from the University of the South with an undergraduate degree.
About PharmAthene, Inc.
PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons.
Sign up for the free Xplosive Stocks newsletter. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by Xplosive Stocks can sign up for free by visiting our website.
About Us
Xplosive Stock is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We focus on Xplosive Stocks and track small cap companies that are on the brink of a financial breakout. To feature a company on our website please contact us at the email listed below.
Please click here to read the full disclaimer.
